Skip to main content

Table 6 Survival sub-analysis at 40 months

From: Pirfenidone improves survival in IPF: results from a real-life study

 

HR

95% CI

P value

Centre

0.28

0.14,0.54

P < 0.0001

Gender

1.72

0.94,3.16

P < 0.077

Age

1.02

1.00,1.05

P < 0.033

FVC

0.97

0.96,0.98

P < 0.0001